Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 132.42 | N/A |
| PEG Ratio (TTM) | -2.06 | N/A |
| P/S Ratio (TTM) | 10.77 | N/A |
| P/B Ratio (TTM) | 2.75 | N/A |
| P/FCF Ratio (TTM) | -140.82 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.18 | N/A |
| Price to 5YR AVG FCF Ratio | -55.71 | N/A |
Profitability (33%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.97% | N/A |
| ROE (TTM) | 2.21% | N/A |
| Net Profit Margin (TTM) | 8.04% | N/A |
| ROIC 5YR AVG | 1.88% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 152.94% | 113.11% | 84.37% |
| Revenue | 0.57% | 13.47% | 12.62% |
| Net Income | 172.64% | 138.70% | 97.88% |
| Cash Flow | 16.69% | 7.25% | 3.55% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.79 | N/A |
| Quick Ratio (TTM) | 0.79 | N/A |
| D/E Ratio (TTM) | 0.80 | N/A |
| Interest Coverage (TTM) | 1.59 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.36 | N/A |
| LTL to 5YR AVG FCF | -143.03 | N/A |
| Shares Outstanding Growth 5YR AVG | 8.04% | N/A |